: WHAT: The Federal Trade Commission and the Justice Department’s Antitrust Division, along with the Department of Commerce and the Department of Health and Human Services, will jointly host the first of three listening sessions focused on discussing ways to make prescription drugs more affordable for Americans by promoting competition. The first listening session will discuss anticompetitive conduct that impedes generic or biosimilar competition. WHEN: Monday, June 30, 2025, 2 pm E.T. WHERE: Attendance in-person is by invitation only, but the event is being streamed online . Members of the public may submit questions online . WHO: The listening session will feature remarks by practitioners and
: Federal Trade Commission Chairman Andrew N. Ferguson today congratulated Mark R. Meador on his confirmation to serve as an FTC Commissioner. “I am thrilled to welcome Mark to the Commission,” Chairman Ferguson said. “Mark is a brilliant antitrust lawyer who will be a great asset to the Trump-Vance FTC.” Meador was nominated on January 20, 2025 by President Trump to a term that will expire on September 25, 2031 and confirmed by the Senate on April 10, 2025. Meador most recently worked in private practice and as a visiting fellow at the Heritage Foundation Tech Policy Center. Prior to that, he served as Deputy Chief Counsel for Antitrust and Competition Policy for Sen. Mike Lee, R-Utah. During the first Trump Administration, Meador worked as a trial attorney in the Department of Justice’s Antitrust Division. He began his career as an attorney in the FTC’s Bureau of Competition. Meador earned his law degree from the University of Houston Law Center and his undergraduate degree in philosophy from the University [...]
: The Federal Trade Commission today finalized a consent order that resolves antitrust concerns surrounding Exxon Mobil Corporation’s (Exxon) acquisition of oil producer Pioneer Natural Resources. The final consent order settles FTC charges first announced in May 2024 . Under the final consent order , Exxon is prohibited from nominating, designating, or appointing founder and former Pioneer CEO Scott Sheffield to the Exxon board or from serving in an advisory capacity in any way to the Exxon board or Exxon’s management. Additionally, the final consent order requires that for a period of five years, Exxon shall not nominate, designate, or appoint any Pioneer employee or director, other than certain named individuals, to the Exxon board. In addition, under the final order, Exxon, for a period of 10 years, will agree to certain Clayton Act Section 8 attestation and reporting obligations. Following a public comment period, the Commission voted 3-2 to approve the final order, with Commissioners Andrew N. Ferguson [...]
: As part of implementing President Trump’s Executive Order No. 14273, Lowering Drug Prices by Once Again Putting Americans First , the Federal Trade Commission and the Justice Department’s Antitrust Division, along with the Department of Commerce and the Department of Health and Human Services, will jointly host listening sessions to discuss ways to make prescription drugs more affordable for Americans by promoting competition. The three listening sessions will occur under the direction of FTC Chairman Andrew N. Ferguson and Assistant Attorney General Gail Slater of the DOJ Antitrust Division. The listening sessions will focus on improving the affordability of pharmaceuticals by increasing generic and biosimilar availability and promoting competition through drug formularies and benefits. The sessions, which will feature remarks by practitioners and scholars, will cover anticompetitive practices as well as eliminating regulatory barriers and rent seeking . The listening sessions will inform the FTC and DOJ’s [...]
: Federal Trade Commission Chairman Andrew N. Ferguson has appointed Emma Mittelstaedt Burnham as Associate Director for Healthcare in the Bureau of Competition. “I am delighted to appoint Emma as Associate Director for Healthcare in the Bureau of Competition. She is a talented attorney with many years of experience at the Department of Justice as a senior antitrust enforcer,” said FTC Chairman Andrew N. Ferguson. “Emma will be an invaluable champion in the FTC’s ongoing fight to protect Americans’ access to affordable, high-quality healthcare.” Emma has significant experience leading the investigation and prosecution of complex antitrust conduct cases, having spent 11 years as a prosecutor at the U.S. Department of Justice Antitrust Division. Most recently, she served as the Director of Criminal Enforcement, supervising the Antitrust Division’s price-fixing matters throughout the United States. She previously held the positions of Trial Attorney, Counsel to the Assistant Attorney General, Assistant Chief, and[...]
: Federal Trade Commission Chairman Andrew N. Ferguson has appointed Daniel Guarnera as Director of the Bureau of Competition. “I am thrilled Dan is joining the FTC as Director of the Bureau of Competition,” said Chairman Ferguson. “He has tremendous experience litigating antitrust cases in critical markets, including agriculture and Big Tech. Few lawyers in America have as much experience taking on Big Tech as Dan. He also has experience using the antitrust laws to promote competition in labor and healthcare markets—two of my top priorities. Under Dan’s leadership, the Bureau of Competition will do its part to fulfill President Trump’s promise to lower the cost of living for all Americans, to promote innovation, and to protect the interests of American workers.” Guarnera joins the Commission from the U.S. Department of Justice Antitrust Division, where he served as chief of the Civil Conduct Task Force. During his tenure, the task force filed monopolization suits against Google and Apple, as well as multiple [...]
: Federal Trade Commission Chairman Andrew N. Ferguson today announced he has appointed Taylor C. Hoogendoorn as Deputy Director of the Bureau of Competition and Katherine White as Deputy Director of the Bureau of Consumer Protection. Hoogendoorn is a talented litigator with expertise in a wide range of litigation, including antitrust, tort, contractual, energy, and intellectual property matters. Hoogendoorn joins the FTC after spending time in private practice at a law firm in Houston. He clerked for the Hon. Samuel A. Alito Jr. on the Supreme Court of the United States; the Hon. Gregory G. Katsas on the United States Court of Appeals for the D.C. Circuit; and the Hon. J. Harvie Wilkinson III on the United States Court of Appeals for the Fourth Circuit. Hoogendoorn holds a J.D. from Yale Law School, where he won the Morris Tyler Moot Court of Appeals and served on the Yale Law Journal, and a B.B.A. with majors in Economics, Finance, Mathematics, and Business Fellows from Baylor University. While at Baylor, h[...]
: On Tuesday, Federal Trade Commission Chairman Andrew N. Ferguson submitted recommendations for deleting or revising anticompetitive regulations across the entire federal government to the White House’s Office of Management and Budget. This report is a response to President Trump’s Executive Order on Reducing Anticompetitive Regulatory Barriers . The Executive Order tasked the FTC with finding unnecessary regulations that exclude new market entrants, protect dominant incumbents, and predetermine economic winners and losers, as a first step to repealing them. “President Trump’s Executive Order recognizes that heavy-handed regulations can hurt competition, including by entrenching incumbent firms, raising costs for new entrants, and discouraging innovative new ways to serve customers,” said FTC Bureau of Competition Director Daniel Guarnera. “Competitive markets lower the cost of living, improve the quality of products and services, and drive innovation. Our engagement with citizens across the country and agenc[...]
: Today, the FTC granted early termination of its review of Mars, Incorporated’s proposed acquisition of Kellanova. Mars is a global manufacturer of pet care, snacking, and food products. Kellanova owns legacy Kellogg brands, including in snacks, crackers, and frozen breakfasts, after spinning off its North American cereals business in 2023 as WK Kellogg Co. “The Commission cares deeply about any competition concerns that affect American consumers, including in food products,” said Daniel Guarnera, Director of the Bureau of Competition. “Commission staff closely reviewed every aspect of this transaction, including both specific product markets and potential portfolio effects from the acquisition. They turned over every stone needed to arrive at a robust assessment of the likely competitive effects of this transaction. After nearly a year of investigation, dozens upon dozens of interviews with non-parties at all levels of the supply chain (including large chains and small, independent businesses), extensive dat[...]
: 7-Eleven, Inc. and its parent company, Seven & i Holdings Co., Ltd., (collectively 7-Eleven) will pay $4.5 million to settle a Federal Trade Commission lawsuit alleging that the convenience store chain violated a 2018 FTC consent order by acquiring a fuel outlet in St. Petersburg, Fla. without providing the Commission prior notice. The $4.5 million penalty marks the largest civil penalty ever collected in an FTC case involving a prior-notice violation. It is also the largest negotiated settlement of any order violation in the FTC Bureau of Competition’s history. “Under the Trump-Vance FTC, merger remedies that protect competition are once again on the table. But for merger remedies to work, firms must abide by the terms of their consent orders, and we will hold parties accountable when they don’t live up to their commitments,” said Daniel Guarnera, Director of the FTC’s Bureau of Competition. “7-Eleven failed to fulfill the terms of the FTC’s consent order and is now paying a record price. The FTC will not h[...]
: The Federal Trade Commission secured a settlement agreement with Southern Glazer’s Wine and Spirits LLC, the nation’s largest distributor of wine and spirits, that will redress allegedly illegal price discrimination practices and make it easier for small businesses to compete against large chain retailers. The sweeping settlement covers nearly all Southern wine and spirits sales to the five largest chain retailers in 26 states. The settlement will also provide direct cash payments to harmed small businesses if an independent monitor finds that Southern violates the settlement order going forward. “This settlement marks a significant milestone for the FTC in its enforcement of the Robinson-Patman Act, which Congress enacted to empower small businesses to compete against large ones,” said Daniel Guarnera, Director of the FTC’s Bureau of Competition. “Small businesses are an invaluable part of the American economy and way of life. The FTC is committed to ensuring that all businesses, no matter their size, can c[...]
: The Federal Trade Commission’s initial findings from its surveillance pricing market study revealed that details like a person’s precise location or browser history can be frequently used to target individual consumers with different prices for the same goods and services. The staff perspective is based on an examination of documents obtained by FTC staff’s 6(b) orders sent to several companies in July aiming to better understand the shadowy market that third-party intermediaries use to set individualized prices for products and services based on consumers’ characteristics and behaviors, like location, demographics, browsing patterns and shopping history. Staff found that consumer behaviors ranging from mouse movements on a webpage to the type of products that consumers leave unpurchased in an online shopping cart can be tracked and used by retailers to tailor consumer pricing. “Initial staff findings show that retailers frequently use people’s personal information to set targeted, tailored prices for goods[...]
: The Federal Trade Commission today moved to block medical device supplier Edwards Lifesciences Corp.’s (Edwards) proposed acquisition of JenaValve Technology, Inc. (JenaValve) due to concerns that the acquisition would limit patient access to lifesaving medical devices used to treat a potentially fatal heart condition. The FTC alleges that over the span of two days in July 2024, Edwards executed agreements to acquire both JenaValve and JC Medical, the two leading companies competing to bring to market transcatheter aortic valve replacement devices that treat a heart condition called aortic regurgitation (TAVR-AR devices). Edwards closed its acquisition of JC Medical in August 2024, and its proposed $945 million acquisition of JenaValve would combine the only two companies with ongoing clinical trials in the United States for a TAVR-AR device. The deal threatens to reduce competition in the TAVR-AR market, likely resulting in reduced innovation, diminished product quality, and potentially increased prices for[...]